CIK 0000885590 · Large accelerated filer
Bausch Health Companies Inc.
Sign in to watch- Ticker
- BHC
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- operating
- Phone
- 514-744-6792
- Business address
- 2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
- Former names
- Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
- 8-K Event Material agreement · New debt or obligation
- SCHEDULE 13D Stake Beneficial Ownership Report
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Grant or award Director acquired 1,062 shares (grant or award)
- 4 Grant or award Director acquired 5,119 shares (grant or award)
- 4 Grant or award Director acquired 9,659 shares (grant or award)
- 8-K Event Other events
- 8-K Event Other events
- 4 Shares withheld for taxes SVP, Controller & CAO gave up 7,961 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 206,849 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, General Counsel gave up 49,292 shares (to pay taxes)
- 4 Grant or award SVP, Controller & CAO acquired 49,823 shares (grant or award)
- 4 Grant or award EVP, US Pharma acquired 108,311 shares (grant or award)
- 4 Grant or award EVP, General Counsel acquired 180,518 shares (grant or award)
- 4 Grant or award EVP, CFO acquired 216,622 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 635,425 shares (grant or award)
- 10-K Report Annual Report
- 8-K Event Results of operations
Page 8 of 121 · 2,419 filings